Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis

Background: Studies of renal denervation (RDN) in patients with apparent treatment resistant hypertension have been hampered by a number of patient and physician related confounders on blood pressure (BP) including poor drug adherence. It remains uncertain whether RDN lowers BP. We aimed to investig...

Full description

Bibliographic Details
Main Authors: Fadl Elmula M. Fadl Elmula, Ying-Mei Feng, Lotte Jacobs, Anne C. Larstorp, Sverre E. Kjeldsen, Alexandre Persu, Jan A. Staessen, for the European Network COordinating research on Renal Denervation (ENCOReD)
Format: Article
Language:English
Published: Taylor & Francis Group 2017-07-01
Series:Blood Pressure
Subjects:
Online Access:http://dx.doi.org/10.1080/08037051.2017.1311769